Shares of First Trust NYSE Arca Biotechnology Index Fund (NYSEARCA:FBT – Get Free Report) reached a new 52-week high on Tuesday . The company traded as high as $261.58 and last traded at $261.0350, with a volume of 3594 shares. The stock had previously closed at $259.63.
First Trust NYSE Arca Biotechnology Index Fund Price Performance
The firm has a 50 day moving average of $247.03 and a 200-day moving average of $221.10. The stock has a market capitalization of $3.00 billion, a P/E ratio of 21.72 and a beta of 0.66.
Institutional Trading of First Trust NYSE Arca Biotechnology Index Fund
A number of institutional investors and hedge funds have recently modified their holdings of the company. HighTower Advisors LLC boosted its stake in First Trust NYSE Arca Biotechnology Index Fund by 4.7% during the fourth quarter. HighTower Advisors LLC now owns 19,709 shares of the company’s stock worth $4,070,000 after buying an additional 882 shares in the last quarter. Harbour Investments Inc. increased its holdings in First Trust NYSE Arca Biotechnology Index Fund by 11.6% in the 4th quarter. Harbour Investments Inc. now owns 6,364 shares of the company’s stock valued at $1,314,000 after buying an additional 659 shares during the period. Envestnet Portfolio Solutions Inc. acquired a new position in shares of First Trust NYSE Arca Biotechnology Index Fund in the 4th quarter valued at $242,000. Forefront Wealth Partners LLC raised its stake in shares of First Trust NYSE Arca Biotechnology Index Fund by 19.3% in the 4th quarter. Forefront Wealth Partners LLC now owns 6,112 shares of the company’s stock valued at $1,262,000 after buying an additional 987 shares in the last quarter. Finally, Sequent Planning LLC acquired a new position in shares of First Trust NYSE Arca Biotechnology Index Fund in the 4th quarter valued at $227,000.
About First Trust NYSE Arca Biotechnology Index Fund
The First Trust NYSE Arca Biotechnology Index Fund (FBT) is an exchange-traded fund that is based on the NYSE Arca Biotechnology index. The fund tracks an equal-weighted index of US biotechnology stocks. FBT was launched on Jun 19, 2006 and is managed by First Trust.
Featured Articles
- Five stocks we like better than First Trust NYSE Arca Biotechnology Index Fund
- Bloom Energy’s AI Surge Meets a Valuation Reality Check
- Target Is Winning Shoppers Back—Can the Rally Reach $180?
- IonQ’s Space Contract Points to a New Frontier for Quantum Investors
- Is Apple’s AI Strategy Smarter Than Skeptics Think?
Receive News & Ratings for First Trust NYSE Arca Biotechnology Index Fund Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for First Trust NYSE Arca Biotechnology Index Fund and related companies with MarketBeat.com's FREE daily email newsletter.
